Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven (NASDAQ:XGN)
· seekingalpha.com
Exagen (XGN) Q2 2026 earnings call: record $19.9M revenue, raised $72–$75M outlook, AVISE CTD growth, margins, and key risks—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...